Influenza, Human: all 2,265 studies

Page 18 of 23. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly SubjectsCompletedNCT01411358Not applicable
• Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly PeopleCompletedNCT01408290Not applicable
• Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and AdolescentsCompletedNCT01407978Not applicable
• Assessment of CR6261, a Monoclonal Antibody Against the Influenza A VirusCompletedNCT01406418Phase 1
• A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza VirusCompletedNCT01405885Phase 1
• Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean ChildrenCompletedNCT01404962Phase 4
• Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly PersonsCompletedNCT01404182Phase 4
• Collaborative Efforts to Increase Flu VaccinationCompletedNCT01403649Not applicable
• A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001CompletedNCT01403155Phase 1
• Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)CompletedNCT01390792
• Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat InfluenzaCompletedNCT01390025Phase 1
• Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu SyndromeCompletedNCT01389518Phase 3
• Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy AdultsCompletedNCT01389479Phase 3
• Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult VolunteersCompletedNCT01389466Phase 1/2
• e- Ab Sensor - Based Real-time Diagnosis of Influenza VirusStatus unknownNCT01388062Not applicable
• H5N1 Vaccine Study in Japanese AdultsCompletedNCT01382329Phase 2/3
• Immune Response to Seasonal Influenza Vaccine in HIV Infected IndividualsCompletedNCT01381029
• Safety Study of Single Administration Intravenous Treatment for InfluenzaTerminatedNCT01375985Phase 1
• Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy AdultsCompletedNCT01369862Phase 1/2
• Comparison of 4 Influenza Vaccines in SeniorsCompletedNCT01368796Phase 4
• Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza VaccineCompletedNCT01368029Phase 1
• Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly SubjectsCompletedNCT01357265Phase 2
• Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years OldCompletedNCT01356342Phase 4
• Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly SubjectsCompletedNCT01356316Phase 4
• Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months OldCompletedNCT01355172Phase 4
• A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy VolunteersCompletedNCT01353729Phase 1
• The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 VaccineCompletedNCT01336166Phase 2
• Safety Study of an Oral Vaccine to Prevent Avian InfluenzaCompletedNCT01335347Phase 1
• Outcomes of Pandemic Influenza in PregnancyStatus unknownNCT01322516
• Flu Vaccine Against Childhood Pneumonia, BangladeshCompletedNCT01319955Phase 3
• H5N1 Mix and Match With AS03CompletedNCT01317758Phase 1
• H5N1 Mix and Match With MF59CompletedNCT01317745Phase 1
• Safety Study of Flufirvitide-3 Nasal Spray in Healthy SubjectsCompletedNCT01313962Phase 1
• Immune Response Study of Influenza VaccineCompletedNCT01310374
• "Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"CompletedNCT01309568
• Convalescent Plasma Treatment in Severe 2009 H1N1 InfectionCompletedNCT01306773Not applicable
• Influenza Vaccination of HIV Infected Pregnant Women: Safety and ImmunogenicityCompletedNCT01306682Phase 2/3
• Influenza Vaccine Trial in HIV Uninfected Pregnant WomenCompletedNCT01306669Phase 3
• Safety of Synbiotics as Adjuvant to Influenza Vaccine in ElderlyCompletedNCT01304771Phase 1
• 2010/2011 Trivalent Influenza VaccinationCompletedNCT01304563Not applicable
• Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in AdultsCompletedNCT01302990Phase 1
• Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)Status unknownNCT01299142Phase 1
• Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In LebanonCompletedNCT01298206
• Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease PatientsCompletedNCT01298102Phase 4
• Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 YearsStatus unknownNCT01289535Phase 4
• Surveillance of Influenza in Paediatric Intensive Care Units in BavariaStatus unknownNCT01286285
• Oseltamivir Infant Influenza Safety StudyCompletedNCT01286142
• Influenza Vaccine Safety and Effectiveness in Healthcare ProvidersCompletedNCT01282177
• Analysis of the Results From Influenza Rapid Test A Positive and H1N1 Real Time RT-PCRStatus unknownNCT01277380
• The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis PatientsCompletedNCT01273974Phase 2/3
• Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU StudyCompletedNCT01271842
• 2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control StrategiesWithdrawnNCT01270685
• Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and NonsmokersCompletedNCT01269723Not applicable
• A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A VaccineCompletedNCT01265914Phase 1
• Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.CompletedNCT01262079
• Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy AdultsStatus unknownNCT01258842Phase 3
• A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy VolunteersCompletedNCT01258530Phase 1
• Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young AdultsCompletedNCT01258062Phase 1
• Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients.Status unknownNCT01256931
• Influenza Virus - A Multicenter RegistryCompletedNCT01256255
• Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant PatientsCompletedNCT01254955
• Household Influenza Transmission StudyCompletedNCT01251679Not applicable
• Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 StudyCompletedNCT01251133Phase 3
• Influenza and Text Messaging in PregnancyCompletedNCT01248520Not applicable
• Swine Flu (Influenza A H1N1) Follow on Vaccine StudyCompletedNCT01239537
• Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years OldCompletedNCT01236040Phase 1
• TIV Infant/Toddler Response Evaluation - Follow-up for Influenza B BoostStatus unknownNCT01235000
• Opting In vs Opting OutCompletedNCT01233804Not applicable
• Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for InfluenzaStatus unknownNCT01227798Phase 1/2
• Influenza Vaccine Challenge Study in Healthy SubjectsCompletedNCT01226758Phase 1
• Gargling With Green Tea for Prophylaxis of Influenza Infection in TeenagersStatus unknownNCT01225770Phase 3
• A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.WithdrawnNCT01224795Phase 3
• Study to Compare Self-administered and Nurse-administered Intradermal Influenza VaccineCompletedNCT01224613Phase 4
• School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification IntensitiesCompletedNCT01224301Not applicable
• A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001CompletedNCT01224262Phase 1/2
• Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and PregnantsCompletedNCT01218685
• Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in KoreaCompletedNCT01215669Phase 4
• Immunogenicity and Safety of V70P5 Revaccination SubjectsCompletedNCT01210898Phase 3
• A Randomized Controlled Trial of the Effectiveness of the Ottawa Influenza Decision AidCompletedNCT01207557Not applicable
• Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign PlannersStatus unknownNCT01207518Not applicable
• The Effect of a Planning Prompt on Seasonal Influenza Vaccination RatesCompletedNCT01207232Not applicable
• The Effect of Time-Slot Scheduling on Flu Vaccination RatesCompletedNCT01206686Not applicable
• Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11CompletedNCT01206114
• A Study of the Pharmacology of Tamiflu in PregnancyCompletedNCT01203527
• Two-site Intradermal Influenza Vaccination in ElderlyCompletedNCT01202552Not applicable
• A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) VaccineCompletedNCT01201902Phase 3
• Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed AdultsCompletedNCT01195038Phase 2
• "COhort Study on A/H1N1 FLU During PREGnancy"CompletedNCT01192737
• Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza VaccinesCompletedNCT01191853
• Vitamin D and the Influenza EpidemicCompletedNCT01182870Phase 3
• Phase 1b Influenza Vaccine Study in Healthy SubjectsCompletedNCT01181336Phase 1
• Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Solid Organ Transplant RecipientsCompletedNCT01180699Not applicable
• Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young ChildrenCompletedNCT01180621Phase 2
• Non-specific Response to H1N1 VaccineCompletedNCT01178918
• Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 InfluenzaCompletedNCT01175122Phase 1
• Influenza Antiviral DAS181-F03CompletedNCT01173224Phase 1
• Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy AdultsCompletedNCT01172054Phase 1
• Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in BrazilTerminatedNCT01171157
• Comparison of Flu Vaccine Doses in ChildrenCompletedNCT01164553Phase 1
• Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly SubjectsCompletedNCT01161264Phase 3

← Influenza, Human overview